Provided by Tiger Trade Technology Pte. Ltd.

Post-Pandemic Stocks

942.615
+1.3410.14%
Number of Gainers:6
Number of Losers:10
Number of Flat:1
PE:- -
High:948.140
Open:941.072
Low:931.273
Close:941.274
Volume:467.94M
Turnover:3.97B
Market Cap:638.59B
Float Cap:527.81B

Loading ...

Fosun Pharma Subsidiary Enters Collaboration Framework and License Agreement

Stock News
·
Aug 17

Shanghai Fosun's Unit in Collaboration with Sandoz AG on 10 Biologic Products

Reuters
·
Aug 17

Shanghai Fosun Pharmaceutical Says to Team up Sandoz on Commercialization, Development, Manufacturing of up to 10 Biologic Products

THOMSON REUTERS
·
Aug 17

Shanghai Fosun Pharmaceutical Says Unit Signs Framework Cooperation Agreement with Sandoz Ag

THOMSON REUTERS
·
Aug 17

UBS Group AG Reduces Stake in Alibaba Health by 8.86 Million Shares at Approximately HK$3.51 Per Share

Deep News
·
Aug 17

CanSino Biologics Says China's Nmpa Accepts New Drug Application for TD5cp Adolescent and Adult

THOMSON REUTERS
·
Aug 16

CanSino Biologics: Td5cp Vaccine for Adolescents and Adults Accepted for New Drug Review

Stock News
·
Aug 16

JD Health International, Inc. (6618) Gets a Buy from CSC Financial

TIPRANKS
·
Aug 16

JD Health (SEHK:6618) Stock Marks Nine Straight Quarters Of Margin Gains

Simply Wall St.
·
Aug 16

Fund investors surprised as institutions sell into strength, with popular healthcare and medical ETFs seeing roughly 3 billion yuan in net outflows recently

Deep News
·
Aug 15

JD Health International, Inc. (6618) Receives a Buy from CLSA

TIPRANKS
·
Aug 15

UBS Group AG Reduces Position in ALI HEALTH by 8.864 Million Shares at Approximately HKD 3.51 Each

Stock News
·
Aug 14

Alibaba Adjusts Exchange Price on Bonds Linked to Alibaba Health Shares to HK$ 5.92

Reuters
·
Aug 14

Tong Ren Tang Technologies Schedules Board Meeting on Interim Results, Dividend Decision

Reuters
·
Aug 14

Alibaba Health Information Technology Stock Falls 2.1% in Hong Kong

Dow Jones
·
Aug 14

Sino Biopharmaceutical Stock Falls 2.0% in Hong Kong, Underperforms Competitors

Dow Jones
·
Aug 14

JD Health Posts $3.4 Billion Net Profit in First Half of 2024, Driven by Drug Sales

Deep News
·
Aug 14

Dual-Listed Stock Premium Ranking: August 14 Market Close

Stock News
·
Aug 14

From Pharmaceuticals to Public Markets: How Great-Sun Foods' CEO Plans a Long-Term Industrial Shift

Deep News
·
Aug 14

CICC Maintains Outperform Rating for JD Health (06618) with Target Price of HK$66.2

Stock News
·
Aug 14